|
[Related PubMed/MEDLINE]
Total Number of Papers: 130
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: RV |
| Long Form |
: resveratrol |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
Acute resveratrol supplementation in coronary artery disease: towards patient stratification. |
CABG, CAD, FMD, PCI |
| 2 |
2020 |
Combined cardio-protective ability of syringic acid and resveratrol against isoproterenol induced cardio-toxicity in rats via attenuating NF-kB and TNF-alpha pathways. |
CK-MB, COMB, ISO, LDH, NF-kB, SA, TEM, TNF-alpha |
| 3 |
2020 |
Enhancement of the cancer inhibitory effect of the bioactive food component resveratrol by nanoparticle based delivery. |
NRV, TPA |
| 4 |
2020 |
Formulation and evaluation of resveratrol loaded cubosomal nanoformulation for topical delivery. |
RC, RC-Gel, RC-Gel |
| 5 |
2020 |
Investigation of molecular mechanisms of experimental compounds in murine models of chronic allergic airways disease using synchrotron Fourier-transform infrared microspectroscopy. |
FPA, LSF, OVA, RLN, S-FTIR, TSA, VPA |
| 6 |
2020 |
Modulation of non-coding RNAs by resveratrol in ovarian cancer cells: In silico analysis and literature review of the anti-cancer pathways involved. |
GO, lncRNAs, miRNAs |
| 7 |
2020 |
Molecular modelling of the antiviral action of Resveratrol derivatives against the activity of two novel SARS CoV-2 and 2019-nCoV receptors. |
--- |
| 8 |
2020 |
Resveratrol bidirectionally regulates insulin effects in skeletal muscle through alternation of intracellular redox homeostasis. |
ROS |
| 9 |
2020 |
Resveratrol suppresses melanoma growth by promoting autophagy through inhibiting the PI3K/AKT/mTOR signaling pathway. |
LC3 |
| 10 |
2019 |
A pH-Induced Reversible Assembly System with Resveratrol-Controllable Loading and Release for Enhanced Tumor-Targeting Chemotherapy. |
Ft, PIRAS |
| 11 |
2019 |
Atorvastatin and Conditioned Media from Atorvastatin-Treated Human Hematopoietic Stem/Progenitor-Derived Cells Show Proangiogenic Activity In Vitro but Not In Vivo. |
ASA, AT, HAoECs, HMOX1, HSPCs, MAC, MET, PACs, PBMCs, SR |
| 12 |
2019 |
Effects of resveratrol and genistein on growth, nutrient utilization and fatty acid composition of rainbow trout. |
DM, FA |
| 13 |
2019 |
Endothelial Cells Deconjugate Resveratrol Metabolites to Free Resveratrol: A Possible Role in Tissue Factor Modulation. |
HAECs, RVmet, TF, TNF-alpha |
| 14 |
2019 |
Evolvement of nutraceutical onion plants engineered for resveratrol biosynthetic pathway. |
--- |
| 15 |
2019 |
Intracellular Delivery of Natural Antioxidants via Hyaluronan Nanohydrogels. |
AX, CU, HA, NHs, ROS |
| 16 |
2019 |
Metabolic profile and structure-activity relationship of resveratrol and its analogs in human bladder cancer cells. |
ARV, ORV, PD |
| 17 |
2019 |
Mitochondria-Targeted and Resveratrol-Loaded Dual-Function Titanium Disulfide Nanosheets for Photothermal-Triggered Tumor Chemotherapy. |
IR780, NIR |
| 18 |
2019 |
Molecular docking analysis of imine stilbene analogs and evaluation of their anti-aging activity using yeast and mammalian cell models. |
CRS, IMS |
| 19 |
2019 |
Protective effects of syringic acid, resveratrol and their combination against isoprenaline administered cardiotoxicity in wistar rats. |
ALT, AST, CK, COMB, GA, GGT, GPx, GST, hs-CRP, ISO, MI, SA, TPC |
| 20 |
2019 |
Resveratrol prevents the development of high blood pressure in spontaneously hypertensive rats through the inhibition of enhanced expression of Gialpha proteins 1. |
BP, SHRs |
| 21 |
2019 |
Resveratrol-delivery vehicle with anti-VEGF activity carried to human retinal pigmented epithelial cells exposed to high-glucose induced conditions. |
Rh6G, VEGF |
| 22 |
2019 |
Role of Resveratrol and Selenium on Oxidative Stress and Expression of Antioxidant and Anti-Aging Genes in Immortalized Lymphocytes from Alzheimer's Disease Patients. |
AD, HCs, LCLs, ROS, Se |
| 23 |
2019 |
Tetramethoxystilbene-Loaded Liposomes Restore Reactive-Oxygen-Species-Mediated Attenuation of Dilator Responses in Rat Aortic Vessels Ex vivo. |
TMS |
| 24 |
2018 |
Beneficial Effects of Resveratrol Administration-Focus on Potential Biochemical Mechanisms in Cardiovascular Conditions. |
BDNF, ROS |
| 25 |
2018 |
Fatty Acid Composition and Fatty Acid Associated Gene-Expression in Gilthead Sea Bream (Sparus aurata) are Affected by Low-Fish Oil Diets, Dietary Resveratrol, and Holding Temperature. |
DHA, DM, EPA |
| 26 |
2018 |
Health Effects of Resveratrol: Results from Human Intervention Trials. |
T2D |
| 27 |
2018 |
PKA-GSK3beta and beta-Catenin Signaling Play a Critical Role in Trans-Resveratrol Mediated Neuronal Differentiation in Human Cord Blood Stem Cells. |
hCB-MSCs |
| 28 |
2018 |
Preparation, characterization, and cellular uptake of resveratrol-loaded trimethyl chitosan nanoparticles. |
EE, TMC, TP-NPs, TPP |
| 29 |
2018 |
Resveratrol alleviates motor and cognitive deficits and neuropathology in the A53T alpha-synuclein mouse model of Parkinson's disease. |
PD |
| 30 |
2018 |
Resveratrol in Patients with Minimal Hepatic Encephalopathy. |
BDI, HRQL, MHE, QOL, STAI |
| 31 |
2018 |
Resveratrol Prevents the Cellular Damages Induced by Monocrotophos via PI3K Signaling Pathway in Human Cord Blood Mesenchymal Stem Cells. |
hUCB-MSC, MCP |
| 32 |
2018 |
Resveratrol protects against sodium nitroprusside induced nucleus pulposus cell apoptosis by scavenging ROS. |
IVD, NAC, NO, NP, PI, PTIO, ROS, SNP |
| 33 |
2018 |
The in vitro radiosensitizer potential of resveratrol on MCF-7 breast cancer cells. |
BC, IR |
| 34 |
2017 |
Differential sensitivities of bladder cancer cell lines to resveratol are unrelated to its metabolic profile. |
HBC, RVS |
| 35 |
2017 |
Fatty Acid Profile Is Modulated by Dietary Resveratrol in Rainbow Trout (Oncorhynchus mykiss). |
--- |
| 36 |
2017 |
Human skin gene expression: Natural (trans) resveratrol versus five resveratrol analogs for dermal applications. |
IL1A |
| 37 |
2017 |
Metabolic Stress Induces Cognitive Disturbances and Inflammation in Aged Mice: Protective Role of Resveratrol. |
HF, OS |
| 38 |
2017 |
Resveratrol prevents angiotensin II-induced hypertrophy of vascular smooth muscle cells through the transactivation of growth factor receptors. |
Ang II, VSMC |
| 39 |
2017 |
Resveratrol-Loaded Albumin Nanoparticles with Prolonged Blood Circulation and Improved Biocompatibility for Highly Effective Targeted Pancreatic Tumor Therapy. |
CCK-8, HP-RGD NPs, HSA, PEG |
| 40 |
2017 |
Synthesis of Novel Imine Stilbene Analogs Exhibiting Potent Anticancer Activity. |
DMOG |
| 41 |
2017 |
The protein restriction mimetic Resveratrol is an autophagy inducer stronger than amino acid starvation in ovarian cancer cells. |
--- |
| 42 |
2016 |
A novel monolithic controlled delivery system of resveratrol for enhanced hepatoprotection: nanoformulation development, pharmacokinetics and pharmacodynamics. |
RV-SLNs, SGOT, SGPT |
| 43 |
2016 |
Differential responses of Trans-Resveratrol on proliferation of neural progenitor cells and aged rat hippocampal neurogenesis. |
ERKs, NPCs |
| 44 |
2016 |
Neuroprotection by combination of resveratrol and enriched environment against ischemic brain injury in rats. |
EE, MCAO |
| 45 |
2016 |
Potentiating the Heat Inactivation of Escherichia coli O157:H7 in Ground Beef Patties by Natural Antimicrobials. |
CH, RT, SEM |
| 46 |
2016 |
Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of alpha-synuclein via SIRT1-deacetylated LC3. |
LC3, MPTP, PD, SIRT1 |
| 47 |
2016 |
Resveratrol attenuates neuronal autophagy and inflammatory injury by inhibiting the TLR4/NF-kappaB signaling pathway in experimental traumatic brain injury. |
CCI, IL, LC3, NeuN, NF-kappaB, TBI, TLR4, TNF |
| 48 |
2016 |
Resveratrol cross-linked chitosan loaded with phospholipid for controlled release and antioxidant activity. |
DLS, FESEM, FTIR, RVC-lipid, TEM, XRD |
| 49 |
2016 |
Resveratrol exerts protective effects on anoxia/reoxygenation injury in cardiomyocytes via miR-34a/Sirt1 signaling pathway. |
ARI, ROS |
| 50 |
2016 |
Resveratrol Pretreatment Protected against Cerebral Ischemia/Reperfusion Injury in Rats via Expansion of T Regulatory Cells. |
I/R, IL-10 |
| 51 |
2016 |
Resveratrol promotes differentiation of mouse embryonic stem cells to cardiomyocytes. |
EBs, ESCs, mESCs |
| 52 |
2016 |
Resveratrol Protects Sepsis-Induced Oxidative DNA Damage in Liver and Kidney of Rats. |
GPx, i.p, MDA, SOD, TNF-alpha |
| 53 |
2016 |
Synthesis and skin gene analysis of 4'-acetoxy-resveratrol (4AR), therapeutic potential for dermal applications. |
4AR, PCNA |
| 54 |
2015 |
Chemopreventive effect of resveratrol and apocynin on pancreatic carcinogenesis via modulation of nuclear phosphorylated GSK3beta and ERK1/2. |
AC |
| 55 |
2015 |
Cross effects of resveratrol and mesenchymal stem cells on liver regeneration and homing in partially hepatectomized rats. |
HGF, IL-6, MSCs, PCNA, PH, TNF-alpha |
| 56 |
2015 |
Dysregulated Ca2+ homeostasis in Fanconi anemia cells. |
FA, NAC |
| 57 |
2015 |
In vitro antiviral effects and 3D QSAR study of resveratrol derivatives as potent inhibitors of influenza H1N1 neuraminidase. |
3D-QSAR, CPE, NA |
| 58 |
2015 |
In vitro protective effects of resveratrol against oxidative damage in human erythrocytes. |
DM, DMPC, DMPE |
| 59 |
2015 |
Inhibition of metalloproteinase activity in FANCA is linked to altered oxygen metabolism. |
BM, FA, FANCA, MMP, MPs, NAC |
| 60 |
2015 |
omega-3 PUFAs and Resveratrol Differently Modulate Acute and Chronic Inflammatory Processes. |
DHA, EPA, PBLs |
| 61 |
2015 |
Resveratrol Ameliorates Clonidine-Induced Endothelium-Dependent Relaxation Involving Akt and Endothelial Nitric Oxide Synthase Regulation in Type 2 Diabetic Mice. |
ACh, eNOS, NO |
| 62 |
2015 |
Resveratrol prevents doxorubicin-induced cardiotoxicity in H9c2 cells through the inhibition of endoplasmic reticulum stress and the activation of the Sirt1 pathway. |
CHOP, DOX, ER, GRP78, NIC |
| 63 |
2015 |
Resveratrol relieves gestational diabetes mellitus in mice through activating AMPK. |
GDM |
| 64 |
2015 |
Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA. |
EGFR, NSCLC, siRNA |
| 65 |
2014 |
Effect of short-term polyphenol treatment on endothelial dysfunction and thromboxane A2 levels in streptozotocin-induced diabetic mice. |
ACh, CA, i.p, MO, NO, STZ, TXB2 |
| 66 |
2014 |
Evaluation of resveratrol and N-acetylcysteine for cancer chemoprevention in a Fanconi anemia murine model. |
FA, NAC |
| 67 |
2014 |
Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity. |
ABR, DPOAEs, TUNEL |
| 68 |
2014 |
One-step reduction and PEGylation of graphene oxide for photothermally controlled drug delivery. |
DeltaPsim, NGO, NIR |
| 69 |
2014 |
Pomegranate Juice Enhances Healthy Lifespan in Drosophila melanogaster: An Exploratory Study. |
PJ |
| 70 |
2014 |
Resveratrol and vitamin E rescue valproic acid-induced teratogenicity: the mechanism of action. |
CEM, HH, VPA |
| 71 |
2014 |
Resveratrol based oral nutritional supplement produces long-term beneficial effects on structure and visual function in human patients. |
AMD, OTC |
| 72 |
2014 |
Resveratrol enhances mitomycin C-mediated suppression of human colorectal cancer cell proliferation by up-regulation of p21WAF1/CIP1. |
MMC |
| 73 |
2014 |
Resveratrol metabolic fingerprinting after acute and chronic intakes of a functional beverage in humans. |
FB, UPLC |
| 74 |
2014 |
Resveratrol protects astrocytes against traumatic brain injury through inhibiting apoptotic and autophagic cell death. |
GSK-3beta, mPTP, ROS, TBI |
| 75 |
2014 |
Resveratrol protects chondrocytes from apoptosis via altering the ultrastructural and biomechanical properties: an AFM study. |
AFM, OA, SNP |
| 76 |
2014 |
Resveratrol protects rabbit articular chondrocyte against sodium nitroprusside-induced apoptosis via scavenging ROS. |
FCM, NO, OA, ROS, SNP |
| 77 |
2014 |
Strategies to improve the solubility and stability of stilbene antioxidants: a comparative study between cyclodextrins and bile acids. |
HP-CDs, PS, PT |
| 78 |
2014 |
The cell membrane is the main target of resveratrol as shown by interdisciplinary biomolecular/cellular and biophysical approaches. |
--- |
| 79 |
2014 |
The proteomic and genomic teratogenicity elicited by valproic acid is preventable with resveratrol and alpha-tocopherol. |
CEM, Vit E, VPA |
| 80 |
2014 |
Treatment of FANCA cells with resveratrol and N-acetylcysteine: a comparative study. |
FA, NAC |
| 81 |
2013 |
Highly efficient biotransformation of polydatin to resveratrol by snailase hydrolysis using response surface methodology optimization. |
RSM |
| 82 |
2013 |
Mechanism of resveratrol on the promotion of induced pluripotent stem cells. |
ESC, iPSCs, MEFs |
| 83 |
2013 |
Modulation of bacterial ghosts--induced nitric oxide production in macrophages by bacterial ghost-delivered resveratrol. |
BGs, NO |
| 84 |
2013 |
Observation of human retinal remodeling in octogenarians with a resveratrol based nutritional supplement. |
AMD, VEGF |
| 85 |
2013 |
Protective effects of resveratrol on sepsis-induced DNA damage in the lymphocytes of rats. |
Fpg |
| 86 |
2013 |
Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells. |
DSBs, IR, NSCLC, SA-beta-gal |
| 87 |
2013 |
Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage. |
DSBs, NAC, NOX5, NSCLC, ROS, SA-beta-gal |
| 88 |
2012 |
Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice. |
FA, HFD |
| 89 |
2012 |
Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats. |
ALT, AST, CAT, gamma-GT, NPSH, SOD, STZ |
| 90 |
2012 |
Plant polyphenols regulate chemokine expression and tissue repair in human keratinocytes through interaction with cytoplasmic and nuclear components of epidermal growth factor receptor system. |
AP-1, EGFR, ERK, IL-8, IP-10, MCP-1, PD, PPs, QR, T/I, TGF-alpha, VB |
| 91 |
2012 |
Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice. |
AMPK, p-IKK, UCP |
| 92 |
2012 |
Resveratrol enhances solar UV-induced responses in normal human epidermal keratinocytes. |
AhR, FICZ, HEK |
| 93 |
2012 |
Resveratrol induces apoptosis via a Bak-mediated intrinsic pathway in human lung adenocarcinoma cells. |
--- |
| 94 |
2012 |
Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt's lymphoma cells by affecting multiple molecular targets. |
EBV, ROS |
| 95 |
2012 |
Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis. |
GBM, sh-STAT3, TIC |
| 96 |
2011 |
Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy. |
ADCC, IC |
| 97 |
2011 |
Modulation of intracellular glutathione affects adipogenesis in 3T3-L1 cells. |
BSO, GCL, GSHest, MCE |
| 98 |
2011 |
Resveratrol blocks Akt activation in angiotensin II- or EGF-stimulated vascular smooth muscle cells in a redox-independent manner. |
Ang II, EGF, NOX, ROS, VSMCs |
| 99 |
2011 |
Resveratrol induces mitochondria-mediated AIF and to a lesser extent caspase-9-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells. |
FCM, FRET, WB |
| 100 |
2011 |
Resveratrol inhibits migration and Rac1 activation in EGF- but not PDGF-activated vascular smooth muscle cells. |
EGF, PDGF, PI3K, VSMC |
|
A Search Service for Abbreviation / Long Form
